baber/WOPTO huggingface dataset:
Patent JP-H11505993-A (JP)
IPC: H04Q3/00
Filed: 1996-05-24
Abstract: PCT No. PCT/EP96/02255 Sec. 371 Date Nov. 11, 1997 Sec. 102(e) Date Nov. 11, 1997 PCT Filed May 24, 1996 PCT Pub. No. WO94/39003 PCT Pub. Date Dec. 5, 1996A method for detecting and compensating for missing and/or incorrectly inserted cells on the reception side in the transmission of ATM cells with an adaptation layer AAL of type 1, the cells being assigned a sequence number and an error detection and correction code which indicates whether or not the sequence number, and additional information dependent thereon, have been transmitted correctly. It is decided on the basis of these data whether a cell is rejected or transmitted on, and whether there are missing or incorrectly inserted cells. A decision regarding the acceptance or the rejection of a received cell is taken directly without waiting for a following cell, while the possible decision as to whether a cell is preceded by one or more missing cells or whether a cell is an incorrectly inserted cell, is taken after the reception of a following cell. In the event that it is decided that the first-mentioned cell is preceded by one or more missing cells, one or more dummy cells with an equal overall number of bytes are inserted between the first-mentioned cell and the aforesaid, following cell. In the event that it is decided that the first-mentioned cell is an incorrectly inserted cell, this incorrectly inserted cell is nevertheless accepted but, for the purpose of compensation, an equal number of bytes of the aforesaid, following cell, and possibly of a cell following that, are rejected.
Patent JP-2000511465-A (JP)
Title: パイプラインのクリーニング方法および装置
IPC: B08B9/032
Filed: 1998-03-10
Abstract: (57)【要約】
流体、特にガス、とりわけ空気と混合されると爆発性混合物を形成するガスを輸送するためのパイプライン（２）をクリーニングする方法であって、回収装置および除去ユニット（５６）によってパイプライン（２）から堆積物を除去することを具備する。パイプライン（２）は、吸引によりパイプラインから流体と堆積物との混合物を取り出し、該堆積物を前記流体から分離して、クリーニングされたガスを前記パイプラインの中に再注入することにより、前記パイプラインはその中を通る流体の流れを中断することなく作動状態でクリーニングされる。本発明によるパイプラインクリーニング法に使用するためのクリーニングユニットは、該クリーニングユニットを前記パイプラインに連結するための第１の手段と、ガスをパージするための入口（１２）と、第１の弁手段（１４，１６）と、ガス／堆積物混合物から機械的に堆積物を分離するための１以上の分離ステージ（１８，２８，３８）と、吸引を生じさせるためのブロワー（４０）と、該ブロワー（４０）に対して並列に接続された第２の弁手段（４８）と、第３の弁手段（５０，５４）と、該クリーニングユニットを前記パイプラインに連結するための第２の手段とを具備し、これらが直列に接続されてなるものである。
Patent JP-2000514831-A (JP)
Title: 医薬用組成物
IPC: A61K38/13
Filed: 1998-03-12
Abstract: (57)【要約】
本発明は、サイクロスポリン含有軟質カプセル製剤に関する。該軟質カプセル製剤は、活性成分としてサイクロスポリン；親水性成分のポリエチレングリコールまたは非親水性成分のプロピレンカーボネートまたはこれらの混合物；オイル成分として、脂肪酸と第一級アルコールのエステル化合物、中級脂肪酸トリグリセリド、脂肪酸モノグリセリドよりなる群から選択される１種または２種以上の混合物；並びにＨＬＢ（親水親油バランス）値が８〜１７の界面活性剤を含有する組成物を含むものである。
Patent JP-2001518787-A (JP)
Title: 核酸ハイブリッド形成検知システムおよびその調製法と応用
IPC: C12Q1/6816
Filed: 1998-04-09
Abstract: (57)【要約】
この発明は、一本鎖ポリヌクレオチドからなる付着ドメインＡ；少なくとも１つの停止シントンからなる中間ドメインＢ；および二本鎖ポリヌクレオチドからなり検出手段を構成する標識されたヌクレオチドを少なくとも１つ組み込む視覚化ドメインＣとからなるプローブを使用する核酸検出に関する。このプローブの使用は核酸ターゲット配列でハイブリッドしたシグナルを増幅させる。
Patent JP-2001520824-A (JP)
Title: 多重ｉ／ｏスタンダードをサポートする入力／出力バッファ
IPC: H03K19/0175
Filed: 1997-08-28
Abstract: (57)【要約】
本発明は２つ又はそれ以上の異なるＩ／Ｏスタンダードのいずれかと適合性を有するべく形態特定することの可能なＦＰＧＡ用の形態特定可能な入力／出力バッファを有している。出力駆動強度、レシーバ型、出力ドライバ型、及び出力信号スルーレート等のファクタが形態特定可能に制御される。幾つかの実施例においては、入力電源及び出力電源をコアの電圧供給源と異なるものとすることが可能である。１実施例においては、同一の形態特定可能な入力バッファ内の２つ又はそれ以上の差動増幅器が異なる入力基準電圧を使用する。本発明の２番目の側面によれば、Ｉ／Ｏパッドが入力基準電圧線へ形態特定可能に接続される。本発明の３番目の側面によれば、Ｉ／Ｏの基準入力が２つ又はそれ以上の入力基準電圧線のうちのいずれかへ形態特定可能に接続される。本発明の別の側面によれば、単一の入力基準電圧又は単一の出力電圧供給が各入力／出力ブロック（ＩＯＢ）へ印加され、複数個のＩＯＢが複数個の組にグループ化される。各組のＩＯＢは別個の入力基準電圧及び／又は別個の出力電圧供給を有している。
Patent JP-2000512193-A (JP)
Title: 組織を骨に係止させるためのシステム
IPC: A61B17/04
Filed: 1998-02-25
Abstract: (57)【要約】
組織を骨に係止するためのシステム（１０）は、骨と係合する外部壁（２２）、遠位端部（１８）、近位端部（２０）、部分的に係止部材の中まで延在し縫合糸定置部（２６）で終端する内部通路を形成する縫合糸通し穴（２８）もつ係止部材（１２）を含む。縫合糸定置部は係止部材と一体であり、係止部材の内部に形成される。
Patent JP-2001527729-A (JP)
Title: チャンネルビットエラー比を推定する方法及び受信器
IPC: H04L1/20
Filed: 1999-03-16
Abstract: (57)【要約】
本発明は、受信器のチャンネルビットエラー比を推定する方法、及び受信器に係る。この方法において、チャンネルの擬似ビットエラー比が決定される。受信器(114)は、受信信号のデータシーケンスを検出するための検出手段(202，204，206，208)と、その検出されたデータ信号の第１エンコードをデコードするためのデコード手段(302)と、第１エンコードからデコードされたデータシーケンスを第１エンコードで再エンコードするための再エンコード手段(310)とを含む。本発明の受信器(114)は、更に、検出されたデータシーケンスにクオリティの値を与えるためのクオリティ決定手段(304)と、検出されたデータシーケンスのクオリティが所定のクオリティ要求を満足する場合に、その検出されたデータシーケンスを、第１エンコードで再エンコードされたデータシーケンスと比較することにより、ビットエラー比を推定するための推定手段(308)とを備えている。第１エンコードは、通常、コンボリューションコード化である。クオリティを決定することのできる１つの方法は、例えば、繰り返し冗長チェックである第２エンコードをデコードすることである。
Patent JP-2000516904-A (JP)
Title: 化学反応器において有用な耐腐蝕性コンポジット
IPC: C30B35/00
Filed: 1998-04-29
Abstract: (57)【要約】
約１０ｐｐｍ、好ましくは約５ｐｐｍ以下の合計金属不純物の水準を有する連続性炭素繊維強化カーボンマトリックスを含む、高純度耐腐蝕性コンポジットから成る化学的処理装置要素。最も好ましくは、このコンポジットは、銀、アルミニウム、バリウム、ベリリウム、カルシウム、カドミウム、コバルト、クロム、銅、カリウム、マグネシウム、マンガン、モリブデン、ナトリウム、燐、ポロニウム、ストロンチウム及び亜鉛の金属に対する誘導結合型プラズマ分光分析の検出限界以下の金属不純物の水準を有する。化学的処理装置で使用する為の上記要素の少なくとも一つを利用する方法であって、前記要素は、ｉ）例えば、処理の為の高純度材料、及びｉｉ）腐蝕性反応媒体の少なくとも一つと接触している。
Patent MD-20030246-A (MD)
Title: Conrod free internal combustion engine
Inventor: MIHAILOV GHEORGHII
IPC: F02B71/04
Filed: 2003-10-16
Abstract: The invention refers to theconrod free internal combustion engines provided for transformation of the pistons reciprocating motion into rotary motion of the working shaftThe engine contains a cylinder 14 partly filled with liquid (H2O or H2O2), a fuel and ignition system. The cylinder 14 partly filled with liquid (H2O or H2O2) is provided with a vessel 12 communicating with an ignition system 17 above the liquid. Supply of the ignition system 17 with fuel is carried out by a cylinder, the piston 11 of which is set in reciprocating motion by the conrod free mechanism. The conrod free mechanism contains a disk 8, and on the circle of the disk 8, with the possibility of rolling onto the body cogged circumference 7, there is articulately installed a pinion 6.
Patent MX-149173-A (MX)
Inventor: ORIOL ANDRE
IPC: B61K7/04
Filed: 1980-02-15
Abstract: 1. A track brake for railway carriages and trucks, comprising jaws and operating by gravity, of the type comprising pairs of articulated levers (1, 2) carrying two braking shoes (4) forming jaws disposed on each side of a vertically mobile running rail (3), characterized in that the levers (1, 2) are provided with tenons (5) articulated in housings serving as bearings formed by a two-part movable flange (6) fixed to the base of the running rail (3) without it being necessary to machine the latter, the hook shape of this flange (6) being adapted to retain the tenons (5) of each of the levers (1, 2) in the angle constituted by the web of the rail and its base, and in that the running rail (3) receiving said levers (1, 2) is constituted by one of the two rails of the running track, previously released from the sleepers by removal of the sleeper screws.
Patent NZ-193618-A (NZ)
Title: Controlled release composition containing hydroxyalkyl starch
Inventor: BERGER K L
IPC: B29C63/00
Filed: 1980-05-05
Abstract: A composition is disclosed for the controlled release administration of a biologically active compound to an animal, comprising a combination of the biologically active compound and hydroxyalkyl starch.
Patent NZ-206837-A (NZ)
Title: Thin film adhesive dressing:backing material in three sections
Inventor: MCCRACKEN R W
IPC: C09J7/02
Filed: 1984-01-13
Abstract: A thin adhesive coated film dressing is provided with the adhesive surface covered by a release paper in three sections to facilitate the application of the dressing to the wound site. The construction of the dressing provides for the center section of the release paper to be removed to expose the central adhesive area of the film. While gripping the film by the two end portions still covered by the release paper, the central portion of the dressing is applied to the wound site. Once the center section is secure, the end sections of the release papers are removed and application of the dressing completed.
Patent NZ-208956-A (NZ)
Title: Pyrimidone derivatives
Inventor: SACH G S
IPC: C07D401/14
Filed: 1984-07-20
Abstract: The present invention provides compounds of formula (2): 
<CHEM>
 and their pharmaceutically acceptable salts which are useful as histamine H1-antagonists. In formula (2)
 Hal is a halogen atom;
 R<5> is an amino group or an pharmaceutically acceptable derivative thereof convertible in vivo to amino;
 R<6> is a C1-3 alkylene group; and
 R<7> is 3-pyridyl, N-oxo-3-pyridyl; 6-methyl-3-pyridyl; N-oxo-6-methyl-3-pyridyl; 6-hydroxymethyl-3-pyridyl; 4,6-dimethyl-3-pyridyl; N-oxo-4,6-dimethyl-3-pyridyl; 6-hydroxymethyl-4-methyl-3-pyridyl; 5,6-dimethyl-3-pyridyl; N-oxo-5,6-dimethyl-3-pyridyl; 6-hydroxy-methyl-5-methyl-3-pyridyl; 4-pyridyl or N-oxo-4-pyridyl.
Patent NZ-219607-A (NZ)
Title: Trans-glutamase inhibitors - oxazole derivatives
Inventor: CASTELHANO ARLINDO LUCAS
IPC: C07D413/12
Filed: 1987-03-13
Abstract: The present invention is directed to certain 3, 5 substituted, 4, 5-dihydroisoxazoles, and methods for their use. These compounds are transglutaminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
Patent NZ-239038-A (NZ)
Title: 1-(pyridinylamino)-1h-indoylcarbamate ester derivative, preparation and pharmaceutical compositions thereof
Inventor: EFFLAND RICHARD CHARLES
IPC: A61K31/535
Filed: 1991-07-19
Abstract: There are disclosed various compounds of the formula below, <CHEM>  where   n   is 0 or 1; X   is hydrogen, halogen, nitro, amino, trifluoromethyl, loweralkyl, or loweralkoxy; Y   is hydrogen, halogen, nitro, amino, trifluoromethyl, loweralkyl, or loweralkoxy; R1   is hydrogen, loweralkyl, arylloweralkyl, loweralkenyl, loweralkynyl, loweralkanoyl, arylloweralkanoyl, heteroarylloweralkyl or heteroarylloweralkanoyl; R2   is hydrogen, loweralkyl, formyl or cyano; R3   is hydrogen or loweralkyl; R4   is loweralkyl, arylloweralkyl, cycloalkyl, aryl or heteroaryl;  or alternatively, -NR3R4 token together constitutes <CHEM>   R5   being hydrogen, loweralkyl, aryl, arylloweralkyl, heteroaryl or heteroarylloweralkyl, which compounds are useful for the treatment of various memory dysfunctions characterized by a cholinergic deficit such as Alzheimer's disease.
Patent NZ-247926-A (NZ)
Title: Dipeptide and dipeptide derivatives having an hydroxamic acid group, their preparation, benzoyl esters and medicaments
Inventor: BROADHURST MICHAEL JOHN
IPC: C07C233/05
Filed: 1993-06-18
Abstract: The invention provides hydroxamic acid derivatives of the formula   <CHEM> wherein R<1> represents 1-7C alkyl; R<2> represents hydrogen, 1-6C alkyl or a group of the formula -(CH2)n-aryl or -(CH2)n-Het in which n stands for 1-4 and Het represents a 5- or 6-membered N-heterocyclic ring which (a) is attached via the N atom, (b) optionally contains N, O and/or S as additional hetero atom(s) in a position or positions other than adjacent to the linking N atom, (c) is substituted by oxo on one or both C atoms adjacent to the linking N atom and (d) is optionally benz-fused or optionally substituted on one or more other carbon atoms by 1-6C alkyl or oxo and/or on any additional N atom(s) by 1-6C alkyl; R<3> represents the characterizing group of a natural or non-natural  alpha -amino acid in which any functional group present may be protected, with the proviso that R<3> does not represent hydrogen; R<4> represents carboxyl, (1-6C alkoxy)-carbonyl, carbamoyl or (1-6C alkyl)carbamoyl; R<5> represents the characterizing group of a naturally occurring  alpha -amino acid in which any functional group present may be protected; and R<6> represents hydrogen; or R<4>, R<5> and R<6> each individually represent hydrogen or 1-6C alkyl, and their pharmaceutically acceptable salts, which are matrix metalloproteinase inhibitors useful for the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteoarthritis or for the treatment of invasive tumours, atherosclerosis or multiple sclerosis. They can be manufactured according to generally known methods by deprotecting a corresponding novel benzyloxyamino compound or hydroxamidating a corresponding novel amino acid or activated derivative thereof.
Patent NZ-268441-A (NZ)
Title: Stable aqueous composition for administration of an active peptide
Inventor: HARRIS ALAN
IPC: A61K38/095
Filed: 1994-06-22
Abstract: Disclosed is a stabilized aqueous composition for administration to a patient comprising a biologically active peptide, a buffer, a quaternary amine-type preservative or disinfectant, and an osmotic pressure-controlling agent, which composition can be stored and used at room temperature. The buffer stabilizes the pH of the composition between about 4 and 6. The preferred buffer contains citrate and/or phosphate, and the preferred preservative or disinfectant is benzalkonium chloride. The composition protects the peptide contained therein from adhering to container surfaces, particularly in containers made of polymeric materials.
Patent NZ-314383-A (NZ)
Title: Interference reduction in spread spectrum cdma
Inventor: SCHILLING DONALD L
IPC: H04B1/707
Filed: 1995-07-05
Abstract: A method for reducing interference in a direct sequence, CDMA receiver, the method comprising the steps of: a) despreading a received spread spectrum signal for each of a plurality of CDMA channels to produce a first estimate for each channel; b) for each channel, spreading the estimate obtained from the prior step for all of the other channels to produce spread other channel signals and subtracting the spread other channel signals from the received signal and despreading the subtracted result to produce a next estimate for that channel; c) repeating step b) a selected number of times; and d) combining the estimates for each channel produced by steps a), b) and c) to output a channel signal for each channel.
Patent NZ-316243-A (NZ)
Title: A cosmetic gel having a soap based gelling agent and a tri or tetra propylene glycol component
Inventor: HILLIARD PETER R
IPC: A61K8/39
Filed: 1996-08-14
Abstract: Disclosed is a glycol-containing base gel composition having reduced skin irritation potential, in which a cosmetically active agent (e.g., deodorant active agent, sunscreen, antiperspirant active agent, etc.) can be incorporated to provide a cosmetic gel (e.g., soft gel or stick) composition. The gelling agent for the gel composition can be a soap. The base gel composition includes at least one glycol having a structure of the formula H(OC3H6)nOH, where n represents the number of repeating propylene oxide groups and ranges from 1-80, with the provisos that: (1) more than zero, and up to 100% by weight, of the glycol component, has n=3 or 4; (2) less than 20% by weight of the glycol component has n=1; (3) not more than 90% by weight of the glycol component has n=2; and (4) not more than 90% by weight of the glycol component has n greater than or equal to 5. The composition can further include a nonionic or anionic surface active agent as a clarifying agent, to provide a translucent or clear gel composition.
Patent NZ-337845-A (NZ)
Title: Non-antigenic branched polymer conjugates
Inventor: GREENWALD RICHARD B
IPC: C08G65/337
Filed: 1998-03-13
Abstract: Branched, substantially non-antigenic polymers designated as (R)n-L-COOH are disclosed. L is depicted above. Conjugates prepared with the polymers and biologically active molecules such as proteins and peptides demonstrate extended circulating life in vivo. Substantially fewer sites on the biologically active material are used as attachment sites. Methods of forming the polymer, conjugating the polymers with biologically active moieties and methods of using the conjugates are also disclosed.
Patent NZ-501061-A (NZ)
Title: Hose reel stand allowing reel to be lifted and rotated about vertical axis, and to be fixed by lowering
Inventor: CROW WALTER JOHN
IPC: F16M11/00
Filed: 1999-11-18
Abstract: The hose reel stand has plate 2 (for receiving reel 1) with peg 4 which locates into holes in plate 5 which is fixed to support post 6. By lifting, rotating and lowering plate 2 reel can be locked into various positions about the vertical axis.
Patent NZ-501124-A (NZ)
Title: cDNA clones of the RSPaV viral strain and associated polypeptides and antibodies thereof
Inventor: MENG BAOZHONG
IPC: C12N7/01
Filed: 1998-05-20
Abstract: An isolated protein or polypeptide corresponding to a protein or polypeptide of a Rupestris stem pitting associated virus (RSPaV) is described.  The encoding DNA molecule, either alone in isolated form, in an expression system, a host cell, or a transgenic grape plant, is also disclosed.  Other aspects relate to a method of imparting Rupestris stem pitting associated virus resistance to grape plants by transforming them with the aforementioned DNA molecule, and a method of detecting the presence of a Rupestris stem pitting associated virus, such as RSPaV-1, in a sample.
Patent NZ-501155-A (NZ)
Title: Breast stabilization device with shape to correspond to upper half of breast, and typically with inner flexible member actuated by suction to contact breast
Inventor: LEE ROBERTA
IPC: A61B6/04
Filed: 1999-11-18
Abstract: Device 100 has side flanges 135, 140 to secure it to flat surface 195. Typically, perforated inner member 320 is drawn by vacuum into intimate contact with breast 124.
Patent NZ-501269-A (NZ)
Title: Device for storing, transporting and displaying miniature figures, with guides for mounting both platforms in cabinet, and base of figures to platforms
Inventor: MERINO MUNOZ ALBERTO
IPC: A47F3/00
Filed: 1999-03-09
Abstract: The device comprises platforms which are intended to place the miniature figures in guides designed to receive the dovetailed bases of the figures. With the disclosed device, it is possible to store collections of figures and further decorate the assembly.
Patent NZ-503003-A (NZ)
Title: Building module consisting of panels spaced by framing members that project out and interlock with adjacent members when panels assembled
Inventor: DUNCAN KATHERINE GAIL
IPC: E04B1/10
Filed: 2000-02-22
Abstract: Modules 1, 2, 3,4, 5 are stacked vertically on assembly. Framing members are located between panels and protrude above and below them, so as adjacent modules have overlapping framing members.
Patent NZ-504052-A (NZ)
Title: Preventing fraudulent interaction with broadcast interactive program
Inventor: MALAURE JASON ROBERT
IPC: H04N7/173
Filed: 2000-04-17
Abstract: In an interactive broadcast system data is broadcast to the users U1, U2, U3 _ from a central control system, and a local clock signal is generated at each user interface.  An interactive application is delivered to a respective user from each user interface with reference to the local clock signal and return data is transmitted to the central control system via the telephone network PSTN by each user interface in response to the delivery of the interactive application.  By comparing the time at which certain of the data is returned to the central control system by the user interfaces in the comparator CCS, a fraudulent user may be detected.
Patent NZ-508947-A (NZ)
Title: Solution comprising prostaglandin drugs, such as dinopost tromethamine, and benzyl alcohol
Inventor: RE ROBERT G
IPC: A61K31/5575
Filed: 1999-06-08
Abstract: Described are new formulations of prostaglandins and methods of preparing the formulations and in particular dinoprost tromethamine, where the pH of the formulation is adjusted to between 5.5 and 7.5 and where the concentration of benzyl alcohol between 1.2 to 2.0 mg/ml.
Patent NZ-513872-A (NZ)
Title: Radioactive cisplatin in the treatment of cancer
Inventor: ORDER STANLEY E
IPC: A61K51/02
Filed: 2000-03-14
Abstract: The use of a composition comprising radioactive cisplatin in the manufacture of a medicament for treating cancer. Also described is the use of a composition comprising an effective amount of radioactive cisplatin for the production of pharmaceutical compositions for the treatment of DNA metabolism in a cell.
Patent NZ-517939-A (NZ)
Title: Water-washable parasiticide composition comprising triflumuron, a surfactant and an organic solvent and a method of treating parasites in an animal
Inventor: LAU KAI KIN
IPC: A01N25/30
Filed: 2002-03-22
Abstract: A water washable parasiticide composition comprising: i) 0.01- 30% w/v of triflumuron, and ii) 0.005 - 30% w/v of one or more surfactants. The balance of the composition is an organic solvent selected from the group consisting of glycols, glycol ethers, glycol ether acetate, C1-8 alkyl pyrrolidones, butyrolactone and mixtures thereof. Also described is a method of treating parasites in an animal, the method comprising administering to the animal and effective amount of the parasiticide compositions described above.
Patent NZ-522290-A (NZ)
Title: Packaging and method for solid dose administration of medicaments
Inventor: HANSEN RICHARD D
IPC: F41A9/84
Filed: 2001-04-24
Abstract: A method and packaging for vaccinating or medicating an animal by implanting a solid dose medicament in an animal. The solid dose medicament, or plurality of such medicaments, are each color-coded to identify a particular active ingredient, then packaged in a pellet magazine through which the doses are visible, and thereafter the pellets are implanted, usually subcutaneously, into the base of the ear or in the neck of an animal. The same system can be used for colored ballistic implants.
Patent NZ-522425-A (NZ)
Title: A therapeutic chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants, use and preparation process thereof
Inventor: AYLWARD JAMES HARRISON
IPC: A61K48/00
Filed: 2001-06-07
Abstract: A therapeutic chemical agents useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects. The present invention further contemplates a method for the prophylaxis and/or treatment in mammalian, animal or avian subjects of infection or potential infection by pathogenic entities by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family of plants or their botanical or horticultural derivatives or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or in the form of a chemical fraction, sub-fraction, preparation or extract of the plant.
Patent NZ-524704-A (NZ)
Title: Biocidal composition for the treatment of water bodies and preparation process thereof
Inventor: BRIGATTI JOHN MURRAY
IPC: A01N59/20
Filed: 2001-08-10
Abstract: A biocidal composition comprising an aqueous suspension of copper (II) oxalate particles for the treatment of water bodies such as lakes or ponds and a method of preparation thereof is disclosed, wherein the preparation process comprises the steps of: dissolving a copper (II) salt in a first portion of water to form an aqueous solution containing copper (II) ions; at least partially dissolving oxalic acid in water to form an aqueous solution/suspension containing oxalic acid/oxalate ions; mixing the solution containing copper (II) ions with the solution/suspension containing oxalic acid/oxalate ions to form a mixture containing copper (II) ions and oxalate ions; and inducing the formation of or allowing the spontaneous formation of solid copper (II) oxalate, and leaving a residual solution. Optionally, after the mixing step, a step of adding an alkaline agent to the mixture containing copper (II) ions and oxalate ions to substantially neutralise any residual acid may also be incorporated into the process.